यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

sanofi winthrop industrie - lixisenatide - diabete mellito, tipo 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

takeda pharma a/s - alogliptin benzoato, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico per migliorare il controllo glicemico in pazienti con insulina a una dose stabile e metformina da sola non forniscono un adeguato controllo glicemico.

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - natrii chloridum, kalii chloridum, calcii chloridum dihydricum, natrii lactas, natrii (s)-lactas, glucosum, natrium, kalium, calcium, chloridum, lactas - soluzione per infusione - natrii chloridum 6 g, kalii chloridum 0.4 g, calcii chloridum dihydricum 0.27 g, natrii lactatis solutio 50% (m/m) corresp. natrii lactas 3.12 g, natrii (s)-lactas 3.12 g, glucosum 50 g ut glucosum monohydricum, acidum hydrochloridum concentratum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, corresp. natrium 130.5 mmol, kalium 5.36 mmol, calcium 1.84 mmol, chloridum 112.5-113 mmol, lactas 27.8 mmol. - reidratazione, leggera, alcalinizzazione, sostituzione del volume, trägerlösung - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

grosse apotheke dr. g. bichsel ag - glucosum, natrium, kalium, calcium, chloridum, lactas - soluzione per infusione - glucosum 10 g ut glucosum monohydricum 11 g, natrii chloridum 6.02 g, kalii chloridum 0.3 g, calcii chloridum dihydricum 0.22 g, natrii lactas 3.14 g, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, corresp. natrium 131 mmol/l, kalium 4 mmol/l, calcium 1.5 mmol/l, chloridum 110 mmol/l, lactas 28 mmol/l, glucosum 55.5 mmol/l. - liquido di sostituzione - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

grosse apotheke dr. g. bichsel ag - glucosum, natrium, kalium, calcium, chloridum, lactas - soluzione per infusione - glucosum 50 g ut glucosum monohydricum 55 g, natrii chloridum 5.96 g, kalii chloridum 0.3 g, calcii chloridum dihydricum 0.22 g, natrii lactas 3.14 g, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, corresp. natrium 130 mmol/l, kalium 4 mmol/l, calcium 1.5 mmol/l, chloridum 109 mmol/l, lactas 28 mmol/l, glucosum 277.5 mmol/l. - liquido di sostituzione - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

grosse apotheke dr. g. bichsel ag - sodio, potassio, calcio, chloridum, lactas - soluzione per infusione - natrii chloridum 6.02 g, kalii chloridum 0.3 g, calcii chloridum dihydricum 0.22 g, natrii lactas 3.14 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml, corresp., natrium 131 mmol/l, kalium 4 mmol/l, calcium 1.5 mmol/l, chloridum 110 mmol/l, lactas 28 mmol/l. - flüssigkeitsersatz - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

baxter ag - glucosum, natrii lactas, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii chloridum, natrii hydrogenocarbonas, natrium, calcium, magnesium, chloridum, hydrogenocarbonas, lactas - peritonealdialyselösung - i) lösung a: glucosum 37.5 g ut glucosum monohydricum 41.25 g, calcii chloridum dihydricum 0.507 g, magnesii chloridum hexahydricum 0.14 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. ii) lösung b: natrii chloridum 8.43 g, natrii hydrogenocarbonas 3.29 g, natrii lactas 2.63 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. lösung nach rekonstitution (362.5 ml lösung a und 637.5 ml lösung b): glucosum 13.6 g ut glucosum monohydricum 15 g, calcii chloridum dihydricum 0.184 g, magnesii chloridum hexahydricum 0.051 g, natrii chloridum 5.38 g, natrii hydrogenocarbonas 2.1 g, natrii lactas 1.68 g, carbonei dioxidum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. natrium 132 mmol, calcium 1.25 mmol, magnesium 0.25 mmol, chloridum 95 mmol, hydrogenocarbonas 25 mmol, lactas 15 mmol. - peritonealdialyselösung - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

baxter ag - glucosum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii chloridum, natrii lactas, natrii hydrogenocarbonas, natrium, calcium, magnesium, chloridum, hydrogenocarbonas, lactas - peritonealdialyselösung - i) lösung a: glucosum 62.6 g ut glucosum monohydricum 68.85 g, calcii chloridum dihydricum 0.507 g, magnesii chloridum hexahydricum 0.14 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. ii) lösung b: natrii chloridum 8.43 g, natrii hydrogenocarbonas 3.29 g, natrii lactas 2.63 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. lösung nach rekonstitution (362.5 ml lösung a und 637.5 ml lösung b): glucosum 22.7 g ut glucosum monohydricum 25 g, calcii chloridum dihydricum 0.184 g, magnesii chloridum hexahydricum 0.051 g, natrii chloridum 5.38 g, natrii hydrogenocarbonas 2.1 g, natrii lactas 1.68 g, carbonei dioxidum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. natrium 132 mmol, calcium 1.25 mmol, magnesium 0.25 mmol, chloridum 95 mmol, hydrogenocarbonas 25 mmol, lactas 15 mmol. - peritonealdialyselösung - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

baxter ag - magnesii chloridum hexahydricum, natrii chloridum, natrii lactas, glucosum, calcii chloridum dihydricum, natrii hydrogenocarbonas, natrium, calcium, magnesium, chloridum, hydrogenocarbonas, lactas - peritonealdialyselösung - i) lösung a: glucosum 106.5 g ut glucosum monohydricum 117.14 g, calcii chloridum dihydricum 0.507 g, magnesii chloridum hexahydricum 0.14 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. ii) lösung b: natrii chloridum 8.43 g, natrii hydrogenocarbonas 3.29 g, natrii lactas 2.63 g, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. lösung nach rekonstitution (362.5 ml lösung a und 637.5 ml lösung b): glucosum 38.6 g ut glucosum monohydricum 42.5 g, calcii chloridum dihydricum 0.184 g, magnesii chloridum hexahydricum 0.051 g, natrii chloridum 5.38 g, natrii hydrogenocarbonas 2.1 g, natrii lactas 1.68 g, carbonei dioxidum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. natrium 132 mmol, calcium 1.25 mmol, magnesium 0.25 mmol, chloridum 95 mmol, hydrogenocarbonas 25 mmol, lactas 15 mmol. - peritonealdialyselösung - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

baxter ag - natrii chloridum, kalii chloridum, calcio chloridum anhydricum, natrii lactas, glucosio, sodio, potassio, calcio, chloridum, lactas - soluzione per infusione - natrii chloridum 6 g, kalii chloridum 0.4 g, calcii chloridum anhydricum 0.27 g, natrii lactas 3.2 g, glucosum 50 g ut glucosum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. corresp. ca. 840 kj, corresp. natrium 131.2 mmol, kalium 5.4 mmol, calcium 1.8 mmol, chloridum 112 mmol, lactas 28.5 mmol. - flüssigkeitsersatz - synthetika